• GSK gets positive CHMP opinion for intravenous Benlysta biospectrumasia
    September 25, 2019
    European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) recommends approval of GSK's IV Benlysta in children with lupus aged five years and above
  • Alexion Receives Positive CHMP Opinion for SOLIRIS americanpharmaceuticalreview
    July 29, 2019
    Alexion Pharmaceuticals announced the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion to extend the current marketing authorization of SOLIRIS® (eculizumab) to ...
PharmaSources Customer Service